Although there are various biomarkers available for other types of cancer, currently only a limited number of molecules such as carcinoembryonic antigen (CEA), CYFRA 21-1, and neuron-specific enolase (NSA) are used in clinical practice for lung cancer. This evidence concerns the gene CEACAM5 and lung cancer.